Please assess the completion status of the following clinical trial:

Trial Title: Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with AML, a certain type of ALL, NHL and MM~* certain types of cancer of the lymph nodes~* certain types of leukemias (blood cancers)~* disease has or will fail with other treatments~* relatively good overall health other than your cancer~Exclusion Criteria:~* poor bone marrow function (not producing enough blood cells)~* serious heart conditions~* poor liver or kidney function

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).